| Name | Title | Contact Details |
|---|
CEDAR: a global educational network enabling members of disparate communities to recognize and accept their differences as they work toward a civil society.
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The companys initial focus is on a pipeline of oral, selective small molecule inhibitors of lymphocyte homing integrin α4β7 for IBD, a mechanism already validated by a commercially available antibody. Enshos assets were acquired from EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., that is focused on gastrointestinal disease. Ensho is preparing to initiate a Phase 2 clinical program in UC with NSHO-101, the lead asset in the companys pipeline.
Maine Poly Aquisition Corp is a Greene, ME-based company in the Business Services sector.
Riverside Captioning Co is a Hudson, WI-based company in the Business Services sector.
Signature Events, LLC is a New Orleans, LA-based company in the Business Services sector.